Illumina Inc. [NASDAQ: ILMN] slipped around -26.04 points on Tuesday, while shares priced at $368.96 at the close of the session, down -6.59%. The company report on March 31, 2021 that Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test.
Illumina, Inc. (NASDAQ: ILMN), announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)’s challenge to its previously announced acquisition of GRAIL, a pre-commercial company founded to accelerate early screening of cancer. Illumina will pursue its right to proceed with the transaction, the impact of which would accelerate the adoption of a breakthrough multi-cancer early detection blood test.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Cancer kills around 10 million people annually worldwide and 600,000 people in the United States alone. Survival rates are higher when cancer is detected early. Seventy-one percent of all deadly cancers do not currently have a screening test. GRAIL’s Galleri test is able to detect more than 50 cancers across all stages, more than 45 of which do not have recommended screening in the United States. And, in 93 percent of the positive results, the test correctly identified the tissue of origin – all with a specificity greater than 99 percent.
Illumina Inc. stock is now -0.28% down from its year-to-date (YTD) trading value. ILMN Stock saw the intraday high of $405.1878 and lowest of $364.241 per share. The company’s 52-week high price is 555.77, which means current price is +3.64% above from all time high which was touched on 02/12/21.
Compared to the average trading volume of 1.12M shares, ILMN reached a trading volume of 4508665 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Illumina Inc. [ILMN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ILMN shares is $408.13 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ILMN stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for Illumina Inc. shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on March 03, 2021. While these analysts kept the previous recommendation, Piper Sandler raised their target price from $340 to $415. The new note on the price target was released on December 22, 2020, representing the official price target for Illumina Inc. stock. Previously, the target price had yet another raise to $410, while BTIG Research analysts kept a Buy rating on ILMN stock.
The Average True Range (ATR) for Illumina Inc. is set at 17.97, with the Price to Sales ratio for ILMN stock in the period of the last 12 months amounting to 16.48. The Price to Book ratio for the last quarter was 11.56, with the Price to Cash per share for the same quarter was set at 24.00. Price to Free Cash Flow for ILMN in the course of the last twelve months was 59.92 with Quick ratio for the last quarter at 3.30.
How has ILMN stock performed recently?
Illumina Inc. [ILMN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.40. With this latest performance, ILMN shares dropped by -17.37% in over the last four-week period, additionally plugging by 20.79% over the last 6 months – not to mention a rise of 33.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ILMN stock in for the last two-week period is set at 33.21, with the RSI for the last a single of trading hit 27.09, and the three-weeks RSI is set at 37.80 for Illumina Inc. [ILMN]. The present Moving Average for the last 50 days of trading for this stock 429.22, while it was recorded at 394.07 for the last single week of trading, and 365.85 for the last 200 days.
Illumina Inc. [ILMN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Illumina Inc. [ILMN] shares currently have an operating margin of +17.91 and a Gross Margin at +68.63. Illumina Inc.’s Net Margin is presently recorded at +20.25.
Return on Total Capital for ILMN is now 8.86, given the latest momentum, and Return on Invested Capital for the company is 10.51. Return on Equity for this stock inclined to 14.10, with Return on Assets sitting at 8.80. When it comes to the capital structure of this company, Illumina Inc. [ILMN] has a Total Debt to Total Equity ratio set at 40.61. Additionally, ILMN Total Debt to Total Capital is recorded at 28.88, with Total Debt to Total Assets ending up at 25.13. Long-Term Debt to Equity for the company is recorded at 28.63, with the Long-Term Debt to Total Capital now at 20.36.
Reflecting on the efficiency of the workforce at the company, Illumina Inc. [ILMN] managed to generate an average of $84,103 per employee. Receivables Turnover for the company is 6.11 with a Total Asset Turnover recorded at a value of 0.43.Illumina Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.30 and a Current Ratio set at 3.60.
Earnings analysis for Illumina Inc. [ILMN]
With the latest financial reports released by the company, Illumina Inc. posted 1.64/share EPS, while the average EPS was predicted by analysts to be reported at 1.25/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 31.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ILMN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Illumina Inc. go to 19.80%.
Insider trade positions for Illumina Inc. [ILMN]
There are presently around $49,338 million, or 93.90% of ILMN stock, in the hands of institutional investors. The top three institutional holders of ILMN stocks are: BAILLIE GIFFORD & CO with ownership of 19,834,762, which is approximately 11.899% of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 11,330,232 shares of the stock with an approximate value of $4.18 billion in ILMN stocks shares; and BLACKROCK INC., currently with $4.15 billion in ILMN stock with ownership of nearly -4.243% of the company’s market capitalization.
Positions in Illumina Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 532 institutional holders increased their position in Illumina Inc. [NASDAQ:ILMN] by around 12,944,959 shares. Additionally, 397 investors decreased positions by around 13,576,888 shares, while 126 investors held positions by with 107,198,804 shares. The mentioned changes placed institutional holdings at 133,720,651 shares, according to the latest SEC report filing. ILMN stock had 162 new institutional investments in for a total of 1,982,829 shares, while 76 institutional investors sold positions of 1,467,081 shares during the same period.